Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$191.17 - $325.63 $95,393 - $162,489
499 Added 7.24%
7,387 $2.41 Million
Q4 2023

Feb 08, 2024

BUY
$160.99 - $215.69 $67,937 - $91,021
422 Added 6.53%
6,888 $1.31 Million
Q3 2023

Oct 27, 2023

BUY
$194.33 - $283.97 $3,109 - $4,543
16 Added 0.25%
6,466 $1.29 Million
Q2 2023

Aug 07, 2023

SELL
$223.05 - $302.68 $35,688 - $48,428
-160 Reduced 2.42%
6,450 $1.84 Million
Q1 2023

May 11, 2023

SELL
$175.41 - $217.92 $130,855 - $162,568
-746 Reduced 10.14%
6,610 $1.43 Million
Q4 2022

Feb 14, 2023

SELL
$204.38 - $296.82 $64,379 - $93,498
-315 Reduced 4.11%
7,356 $1.51 Million
Q3 2022

Nov 14, 2022

SELL
$195.21 - $310.53 $18,935 - $30,121
-97 Reduced 1.25%
7,671 $2.11 Million
Q2 2022

Aug 12, 2022

SELL
$115.91 - $214.48 $26,775 - $49,544
-231 Reduced 2.89%
7,768 $1.49 Million
Q1 2022

May 11, 2022

SELL
$127.96 - $207.36 $3,454 - $5,598
-27 Reduced 0.34%
7,999 $1.66 Million
Q4 2021

Feb 14, 2022

SELL
$165.13 - $241.83 $28,897 - $42,320
-175 Reduced 2.13%
8,026 $1.43 Million
Q3 2021

Nov 04, 2021

SELL
$163.99 - $235.57 $4,919 - $7,067
-30 Reduced 0.36%
8,201 $1.69 Million
Q2 2021

Aug 03, 2021

SELL
$131.45 - $201.49 $16,036 - $24,581
-122 Reduced 1.46%
8,231 $1.56 Million
Q1 2021

May 10, 2021

BUY
$92.73 - $142.05 $8,345 - $12,784
90 Added 1.09%
8,353 $1.09 Million
Q4 2020

Feb 12, 2021

SELL
$67.44 - $103.72 $7,216 - $11,098
-107 Reduced 1.28%
8,263 $857,000
Q3 2020

Nov 04, 2020

BUY
$42.79 - $75.8 $7,488 - $13,265
175 Added 2.14%
8,370 $634,000
Q2 2020

Aug 14, 2020

SELL
$27.25 - $47.53 $953 - $1,663
-35 Reduced 0.43%
8,195 $388,000
Q1 2020

Apr 29, 2020

BUY
$23.16 - $47.74 $8,106 - $16,709
350 Added 4.44%
8,230 $273,000
Q4 2019

Feb 13, 2020

BUY
$29.4 - $44.98 $18,228 - $27,887
620 Added 8.54%
7,880 $346,000
Q3 2019

Nov 13, 2019

BUY
$29.71 - $55.23 $215,694 - $400,969
7,260 New
7,260 $217,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Financial Advocates Investment Management Portfolio

Follow Financial Advocates Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advocates Investment Management with notifications on news.